0.9101
price down icon15.73%   -0.1699
after-market After Hours: .90 -0.0101 -1.11%
loading

Anebulo Pharmaceuticals Inc Stock (ANEB) Forecast

The Anebulo Pharmaceuticals Inc (ANEB) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.2109, representing a -76.82% decrease from the current price of $0.9101. The highest analyst price target is $0.3939, and the lowest is $0.028.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ANEB Price Target
Average 0.9035 (-0.72% Downside)
loading

Is Anebulo Pharmaceuticals Inc (ANEB) A Buy Now?

Oscillators
Name Value Action
RSI(14) 23.71 Buy
STOCH(9,6) 38.99 Neutral
STOCHRSI(14) 95.63 Sell
MACD(12,26) -0.1953 Buy
ADX(14) 53.86 Sell
William %R -92.40 Buy
CCI(14) -159.74 Sell
Buy: 3 Sell: 3 Neutral: 1
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
1.069
Sell
1.0698
Sell
MA20
1.0883
Sell
1.1947
Sell
MA50
1.7331
Sell
1.5827
Sell
MA100
2.0989
Sell
1.8425
Sell
MA200
1.8931
Sell
1.9016
Sell
Buy: 0 Sell: 10 Neutral: 0
Summary: Sell
According to our latest analysis, ANEB could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 13 signaling Sell signals and 1 Neutral signals. This might not be a good time to consider opening new positions on ANEB, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 23.71 indicates that ANEB is oversold. This indicates that ANEB price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
  2. STOCH (Stochastic Oscillator): The STOCH value of 38.99 indicates that ANEB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 95.63 indicates that ANEB is oversold. This suggests that ANEB price is at or near the highest level relative to its recent price history.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 53.86 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -159.74 indicates that ANEB is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.

Long-term ANEB price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Anebulo Pharmaceuticals Inc financial reports and earnings history, Anebulo Pharmaceuticals Inc (ANEB) stock could reach $1.9418 by 2030, $16.92 by 2040 and $25.98 by 2050. See the projected annual prices until 2050 of the Anebulo Pharmaceuticals Inc stock below:

  • Anebulo Pharmaceuticals Inc (ANEB) is expected to reach an average price of $9.4353 in 2035, with a high prediction of $9.0871 and a low estimate of $8.8882. This indicates an $936.74% rise from the last recorded price of $0.9101.
  • Anebulo Pharmaceuticals Inc (ANEB) stock is projected to chart a bullish course in 2040, with an average price target of $17.13, representing an $1,782% surge from its current level. The forecast ranges from a conservative $5.6577 to a sky-high $16.92.
  • Our analysts predict Anebulo Pharmaceuticals Inc (ANEB) to jump 1,638% by 2045, soaring from $15.91 to an average price of $15.82, potentially reaching $15.76. While $15.91 is the low estimate, the potential upside is significant.
  • Anebulo Pharmaceuticals Inc (ANEB) stock is expected to climb by 2050, reaching an average of $25.66, a $2,720% jump from its current level. However, a wide range of estimates exists, with high and low targets of $25.98 and $25.66, respectively, highlighting the market's uncertainty.

Anebulo Pharmaceuticals Inc Stock (ANEB) Year by Year Forecast

Anebulo Pharmaceuticals Inc Stock (ANEB) Price Forecast for 2026

The predicted value for Anebulo Pharmaceuticals Inc (ANEB) in 2026 is set at an average of $0.9035. Estimates vary from a peak of $1.7953 to a trough of $0.0117, indicating an -0.72% surge from the present price of $0.9101.
Month Average Low High Change from today's price
February, 2026 $0.028 $0.028 $0.3939 -96.93%
March, 2026 $0.2644 $0.0117 $0.6721 -70.95%
April, 2026 $0.1349 $0.0126 $0.5685 -85.17%
May, 2026 $0.2486 $0.2486 $0.2678 -72.68%
June, 2026 $0.2719 $0.1903 $0.3196 -70.13%
July, 2026 $0.1872 $0.1057 $0.1492 -79.43%
August, 2026 $0.4748 $0.1434 $1.0347 -47.83%
September, 2026 $0.9453 $0.213 $1.7953 +3.87%
October, 2026 $0.2619 $0.0482 $1.4695 -71.23%
November, 2026 $0.1018 $0.0401 $0.7859 -88.82%
December, 2026 $0.2988 $0.0454 $0.4764 -67.17%

Anebulo Pharmaceuticals Inc Stock (ANEB) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Anebulo Pharmaceuticals Inc (ANEB) is $0.796, with a high forecast of $1.5391 and a low forecast of $0.0529. This indicates an -12.54% decrease from the last price of $0.9101.
Month Average Low High Change from today's price
January, 2027 $0.4052 $0.0529 $0.816 -55.48%
February, 2027 $0.4666 $0.2993 $0.5865 -48.73%
March, 2027 $0.9622 $0.5057 $1.3981 +5.72%
April, 2027 $0.7086 $0.5886 $1.4045 -22.14%
May, 2027 $1.13 $0.5827 $1.3509 +24.16%
June, 2027 $1.0582 $0.8632 $1.5391 +16.27%
July, 2027 $1.1735 $1.0017 $1.0235 +28.95%
August, 2027 $1.2607 $1.1089 $0.7671 +38.52%
September, 2027 $0.9796 $0.8778 $0.9958 +7.63%
October, 2027 $1.2866 $1.0021 $0.8967 +41.37%
November, 2027 $0.8438 $1.2621 $0.8685 -7.28%
December, 2027 $0.3028 $0.5558 $0.7156 -66.73%

Anebulo Pharmaceuticals Inc Stock (ANEB) Price Forecast for 2028

In 2028, Anebulo Pharmaceuticals Inc (ANEB) is projected to reach an average price of $1.9226, with a high projection of $3.662 and a low estimate of $0.1832. This indicates an +111.25% rise from the last price of $0.9101.
Month Average Low High Change from today's price
January, 2028 $0.4999 $0.3981 $0.6669 -45.07%
February, 2028 $0.357 $0.427 $0.673 -60.77%
March, 2028 $0.2041 $0.1832 $0.8594 -77.58%
April, 2028 $3.1131 $0.5977 $2.3231 +242.06%
May, 2028 $3.982 $3.0101 $3.662 +337.53%
June, 2028 $1.5791 $3.7991 $3.3838 +73.51%
July, 2028 $3.3563 $1.5994 $1.8462 +268.78%
August, 2028 $2.8152 $2.5934 $3.2098 +209.33%
September, 2028 $2.3523 $2.9923 $2.8565 +158.47%
October, 2028 $3.0694 $2.7141 $2.9076 +237.27%
November, 2028 $3.1984 $3.3384 $3.4748 +251.43%
December, 2028 $3.6355 $3.4683 $3.4055 +299.46%

Anebulo Pharmaceuticals Inc Stock (ANEB) Price Forecast for 2029

The 2029 price forecast for Anebulo Pharmaceuticals Inc Stock (ANEB) is $2.1936 on average, with a high prediction of $3.1562 and a low estimate of $1.2311. This represents an +141.03% increase from the previous price of $0.9101.
Month Average Low High Change from today's price
January, 2029 $3.2707 $3.1791 $2.8973 +259.38%
February, 2029 $2.9214 $3.0098 $3.1562 +221.00%
March, 2029 $2.5537 $2.6787 $2.8333 +180.59%
April, 2029 $2.5559 $2.5401 $2.3905 +180.84%
May, 2029 $2.4246 $2.5628 $2.4794 +166.41%
June, 2029 $2.7769 $2.4065 $2.7769 +205.12%
July, 2029 $2.479 $2.699 $2.7037 +172.39%
August, 2029 $2.4568 $2.5639 $2.5543 +169.95%
September, 2029 $2.575 $2.5015 $2.575 +182.94%
October, 2029 $1.804 $1.8522 $1.654 +98.22%
November, 2029 $1.2011 $1.2311 $1.9057 +31.97%
December, 2029 $1.6882 $1.4529 $1.3982 +85.50%

Anebulo Pharmaceuticals Inc Stock (ANEB) Price Forecast for 2030

Anebulo Pharmaceuticals Inc Stock (ANEB) is expected to reach an average price of $2.7437 in 2030, with a high forecast of $4.9853 and a low forecast of $0.5021. This signifies an +201.47% surge from the last price of $0.9101.
Month Average Low High Change from today's price
January, 2030 $2.0671 $2.1299 $1.9418 +127.13%
February, 2030 $1.7843 $1.9575 $1.859 +96.05%
March, 2030 $1.6014 $1.6296 $1.7561 +75.96%
April, 2030 $1.3135 $1.4385 $1.4668 +44.33%
May, 2030 $1.0275 $0.9257 $1.1603 +12.90%
June, 2030 $1.1346 $0.9692 $1.1146 +24.67%
July, 2030 $0.7899 $0.7717 $0.6991 -13.21%
August, 2030 $4.9443 $0.5021 $4.9443 +443.27%
September, 2030 $4.9457 $4.9776 $4.9853 +443.42%
October, 2030 $5.0513 $4.8871 $4.8871 +455.03%
November, 2030 $4.482 $4.7267 $4.362 +392.48%
December, 2030 $5.2927 $4.9774 $4.6751 +481.56%
$99.82
price up icon 2.09%
$103.47
price up icon 0.87%
$34.40
price up icon 2.78%
$119.34
price up icon 1.14%
$162.64
price up icon 1.83%
biotechnology ONC
$336.16
price down icon 0.48%
Cap:     |  Volume (24h):